David Burns

    • Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction  

    • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

    • Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals 

    • ThoughtSpot Brings Valuation to $4.2 Billion With Series F Round 

    • NeoPhotonics Agrees to Sell to Lumentum for $918 Million 

    • Virtual Reality Developer Within Agrees to Sell to Meta 

    • SeatGeek to Combine With SPAC RedBall Acquisition Corp. 

    • Otsuka Enters Worldwide Collaboration Agreement With Sunovion and Sumitomo Dainippon Pharma 

    • Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion 

    • IRL Reaches Unicorn Status With Series C Round 

    • Snapdocs Valuation Climbs to Over $1.5 Billion With Series D Round 

    • The Honest Company – $475 Million IPO 

    • Five Prime Therapeutics Agrees to Sell to Amgen for $1.9 Billion 

    • Gopuff More Than Doubles Valuation in Five Months With $1.15 Billion Funding Round 

    • Horizon Therapeutics to Acquire Viela Bio 

    • VelosBio Agrees to Sell to Merck for $2.75 Billion 

    • goPuff Hits $3.9 Billion Valuation With Latest Funding Round 

    • Vir Biotechnology - $143 Million IPO 

    • Uber Closes SoftBank Investment 

    • Patheon Prevails in Antitrust Battle with Procaps 

    • NetScout Receives DOJ Clearance After Second Request in $2.6 Billion Acquisition 

    • Auspex Pharma $3.5 billion sale to Teva Pharma 

    • Auspex Pharma Acquired by Teva for $3.5 Billion 

    • Antitrust Team Clears Tesoro for $1.175 Billion Acquisition 

    • Appellate Court Affirms Victory for Patheon in Antitrust Suit with Procaps